In a recent exclusive interview, Fierce Biotech’s Chris Hayden sat down with Alex MacDonald, Vice President of Model-Informed Drug Development at Allucent, to explore the impact of Project Optimus, an ...
HOUSTON, July 08, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (PSTV) (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced ...
The field of high dose rate (HDR) brachytherapy has witnessed rapid advances in optimisation techniques that aim to balance the dual imperatives of maximising tumour dose while minimising exposure to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback